- Thursday, March 30, 2023
7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
Location: Exhibit Hall
7:00 AM – 8:00 AM
Non-CE Symposia: Advances in AML Therapy: Practical Management of a BCL2-Inhibitor
7:00 AM – 8:00 AM
Non-CE Symposia: Advances in AML Therapy: Practical Management of a BCL2-InhibitorLocation: 158
Ryan Beechinor, PharmD, BCSP, BCOP ### 1896093###*Speaker#########*Speaker:
### 7:00 AM – 8:00 AM
Non-CE Symposia: Title TBD (AstraZeneca)
7:00 AM – 8:00 AM
Non-CE Symposia: Use of a Targeted Agent For Previously Untreated or R/R CLLLocation: 159
Mark Wagner, PharmD ### 1917234###*Speaker#########*Speaker:
### 8:00 AM – 9:00 AM
Considerations in Opioid Tapering in Cancer Survivors
8:00 AM – 9:00 AM
201 - Considerations in Opioid Tapering in Cancer SurvivorsLocation: 164-167Speaker: – Vanderbilt University Medical Center
Taylor W. Butler, PharmD, BCOP, BCPS (he/him/his) – Vanderbilt University Medical Center ### 1774206###Speaker###Clinical Pharmacy Specialist - Cancer Pain###Vanderbilt University Medical Center###Speaker: – Vanderbilt University Medical Center
### he/him/his
8:00 AM – 9:00 AM
Current Approaches to Manage Mixed Phenotype Acute Leukemia (MPAL): A Recent Patient Case Analysis
8:00 AM – 9:00 AM
202 - Current Approaches in the Management of Mixed Phenotype Acute Leukemia (MPAL)Location: 160-163Speaker: – Brigham and Women's Hospital, Harvard Medical School
Jian Ni, Pharm.D., MPH, BCOP – Brigham and Women's Hospital, Harvard Medical School ### 1774208###Speaker###Oncology Pharmacy Clinical Specialist###Brigham and Women's Hospital, Harvard Medical School ###Speaker: – Brigham and Women's Hospital, Harvard Medical School
###
8:00 AM – 9:00 AM
From Blame & Shame We Overcame: Establishing a Multidisciplinary Cancer Medication Safety Committee
8:00 AM – 9:00 AM
203 - From Blame & Shame We Overcame: Establishing a Multidisciplinary Oncology Medication Safety CommitteeLocation: BallroomSpeaker: – University of Kansas Health System
Practice Management
Grace A. Martin, PharmD, BCOP – University of Kansas Health System ### 1774210###Speaker###Pharmacy Clinical Coordinator - Cancer Care###University of Kansas Health System###Speaker: – University of Kansas Health System
###
8:00 AM – 9:00 AM
Impact of Payor Driven Treatment Site of Care Initiatives: Balancing Safety, Quality and Cost
8:00 AM – 9:00 AM
203 - Treatment Site of Care Initiatives: Balancing Safety, Quality and CostLocation: BallroomPractice Management
Prabha Vogel, PharmD, BCOP, BCPS – Self Employed ### 1774209###Speaker###Consultant###Self Employed###Speaker: – Self Employed
###
8:00 AM – 9:00 AM
Polatuzumab-vedotin in upfront diffuse large b-cell lymphoma: efficacy versus financial toxicity
8:00 AM – 9:00 AM
202 - Polatuzumab-vedotin in Upfront Treatment of DLBCL: Overview of POLARIX Trial and Financial ConsiderationsLocation: 160-163Speaker: – Memorial Sloan Kettering Cancer Center
Andrea LeVoir, BCOP – Memorial Sloan Kettering Cancer Center ### 1171482###Speaker###Clinical Pharmacy Specialist###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
###
8:00 AM – 9:00 AM
What’s the risk? Update on the safe use of medicines in G6PD deficiency
8:00 AM – 9:00 AM
201 - What’s the Risk? Update on the Safe Use of Medicines in G6PD DeficiencyLocation: 164-167Speaker: – St. Jude Children's Research Hospital
Cyrine E. Haidar, PharmD, BCPS, BCOP, FASHP – St. Jude Children's Research Hospital ### 1772978###Speaker###Clinical Pharmacogenomics Senior Program Manager###St. Jude Children's Research Hospital###Speaker: – St. Jude Children's Research Hospital
###
9:15 AM – 10:30 AM
HOPA-ASCO Quality Training Program (QTP) 6-month Program Participants: Panel Discussion
9:15 AM – 10:30 AM
204 - HOPA-ASCO Quality Training Program (QTP) 6-month Program Participants Panel DiscussionLocation: BallroomLead Presenter: – Pharmacy Times Continuing Education
Lead Presenter: – University of Michigan Rogel Cancer Center
Practice Management
Amy L. Morris, PharmD – Pharmacy Times Continuing Education ### 1504251###Lead Presenter###Scientific Director, Oncology###Pharmacy Times Continuing Education###Lead Presenter: – Pharmacy Times Continuing Education
### @@@ Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###Lead Presenter###Clinical Pharmacist###University of Michigan Rogel Cancer Center###Lead Presenter: – University of Michigan Rogel Cancer Center
###
10:45 AM – 12:00 PM
Controversies in Precision Oncology: Interpreting the Grey Areas
10:45 AM – 12:00 PM
205 - Controversies in Precision Oncology: Interpreting the Grey AreasLocation: 160-163Co-Speaker: – William S. Middleton Memorial Veterans Hospital
Co-Speaker: – Veterans Health Administration
Co-Speaker: – Moffitt Cancer Center
Jennie Piccolo, PharmD, BCOP (she/her/hers) – William S. Middleton Memorial Veterans Hospital ### 1774214###Co-Speaker###Clinical Hematology/Oncology Pharmacist Practitioner; National Precision Oncology Program Consultant###William S. Middleton Memorial Veterans Hospital###Co-Speaker: – William S. Middleton Memorial Veterans Hospital
### she/her/hers @@@ Ni-Chi Wu, PharmD, BCOP, BCPS – Veterans Health Administration ### 1518441###Co-Speaker###National TeleOncology Clinical Pharmacy Practitioner/National Precision Oncology Program Consultant###Veterans Health Administration###Co-Speaker: – Veterans Health Administration
### @@@ Christine M. Walko, PharmD, BCOP, FCCP (she/her/hers) – Moffitt Cancer Center ### 1390144###Co-Speaker###Associate Member, Department of Individualized Cancer Management, Precision Medicine Program Lead and Precision Medicine Clinical Service Attending###Moffitt Cancer Center###Co-Speaker: – Moffitt Cancer Center
### she/her/hers
10:45 AM – 12:00 PM
Evolving Landscape of Early Non-Small Cell Lung Cancer
10:45 AM – 12:00 PM
BC3 - The Constant Gardener: The Evolving Landscape of Early Non-Small Cell Lung CancerLocation: BallroomSpeaker: – University of Texas MD Anderson Cancer Center
BCOP
Whitney E. Lewis, PharmD, BCOP – University of Texas MD Anderson Cancer Center ### 1491265###Speaker###clinical pharmacy specialist###University of Texas MD Anderson Cancer Center###Speaker: – University of Texas MD Anderson Cancer Center
###
12:00 PM – 1:00 PM
Non-CE Symposia: Janssen Oncology invites you to learn more about a new treatment option for patients diagnosed with multiple myeloma who are relapsed/refractory and have received >=4 prior lines of therapy.
12:00 PM – 1:00 PM
Non-CE Symposia: Janssen Oncology invites you to learn more about a new treatment option for patients diagnosed with multiple myeloma who are relapsed/refractory and have received >=4 prior lines of therapy.Location: 157*Speaker: – M Health Fairview and Mayo Clinic College of Medicine
Kirollos Hanna, BCOP, BCPS, PharmD – M Health Fairview and Mayo Clinic College of Medicine ### 894762###*Speaker###Director of Pharmacy###M Health Fairview and Mayo Clinic College of Medicine###*Speaker: – M Health Fairview and Mayo Clinic College of Medicine
### 12:00 PM – 1:00 PM
Non-CE Symposia: A Treatment Option for Patients with Gastroesophageal Cancers
12:00 PM – 1:00 PM
Non-CE Symposia: A Treatment Option for Patients with Gastroesophageal CancersLocation: 159
Jeryl Villadolid ### 1922354###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Non-CE Symposia: Discussion of BRUKINSA for adult patients with CLL/SLL
12:00 PM – 1:00 PM
Non-CE Symposia: Discussion of BRUKINSA for adult patients with CLL/SLL Location: 158
Justin D. Andras, PharmD, BCOP ### 1920043###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Preparing for a Career in Hematology/Oncology Pharmacy Practice (Non-CE)
12:00 PM – 1:00 PM
Preparing for a Career in Hematology/Oncology Pharmacy Practice (Non-CE)Location: 160-163Speaker:
Speaker: – Atrium Health Wake Forest Baptist (WFB)
Speaker: – St. John's University
Speaker: – University of Kansas Cancer Center
Speaker: – MD Anderson Cancer Center
Sally Barbour, PharmD, BCOP, FHOPA ### 1917281###Speaker#########Speaker:
### @@@ LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA – Atrium Health Wake Forest Baptist (WFB) ### 1311883###Speaker###Clinical Specialist - Stem Cell Transplant and Cellular Therapy###Atrium Health Wake Forest Baptist (WFB)###Speaker: – Atrium Health Wake Forest Baptist (WFB)
### @@@ Chung-Shien Lee, PharmD, BCPS, BCOP – St. John's University ### 894784###Speaker###Assistant Professor###St. John's University###Speaker: – St. John's University
### @@@ Zahra Mahmoudjafari, PharmD, MBA, BCOP (she/her/hers) – University of Kansas Cancer Center ### 958456###Speaker###Clinical Pharmacy Manager-Hem/BMT/CAR-T###University of Kansas Cancer Center###Speaker: – University of Kansas Cancer Center
### she/her/hers @@@ Jason Yeh, PharmD, BCOP – MD Anderson Cancer Center ### 1518443###Speaker###Clinical Pharmacy Specialist / PGY2 Oncology Pharmacy RPD###MD Anderson Cancer Center###Speaker: – MD Anderson Cancer Center
### 12:00 PM – 1:00 PM
Quality Improvement
12:00 PM – 1:00 PM
Navigating the Sea of Quality Improvement: Charting Course Toward Successful Residency Projects. A Panel Discussion (non-CE)Location: 164-167Lead Facilitator: – University of Virginia Health
Co-Speaker: – University of Virginia Health
Co-Speaker: – Dana-Farber Cancer Institute
Co-Speaker: – Dana Farber Cancer Institute
Kathlene DeGregory, PharmD, BCOP (she/her/hers) – University of Virginia Health ### 1188659###Lead Facilitator###Clinical Pharmacist Stem Cell Transplant###University of Virginia Health###Lead Facilitator: – University of Virginia Health
### she/her/hers @@@ Hiba Alzouby, PharmD – University of Virginia Health ### 1913944###Co-Speaker###PGY2 Oncology Pharmacy Resident###University of Virginia Health###Co-Speaker: – University of Virginia Health
### @@@ Gayle C. Blouin, BCOP,PharmD,RPh (she/her/hers) – Dana-Farber Cancer Institute ### 958461###Co-Speaker###Clinical Pharmacy Manager###Dana-Farber Cancer Institute###Co-Speaker: – Dana-Farber Cancer Institute
### she/her/hers @@@ Yun Man, PharmD, BCOP (she/her/hers) – Dana Farber Cancer Institute ### 1552964###Co-Speaker###Medication Use Quality and Policy Specialist###Dana Farber Cancer Institute###Co-Speaker: – Dana Farber Cancer Institute
### she/her/hers
12:00 PM – 1:00 PM
Special Interest Group (SIG) Networking Luncheon
12:00 PM – 1:00 PM
Special Interest Group (SIG) Networking Luncheon
Location: Networking Lounge
12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
Location: Ballroom Lobby
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Odd #)
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Odd #)Location: Exhibit HallResearch
2:15 PM – 3:15 PM
John G. Kuhn Keynote Address: I’m Not Limping. That’s Swagger! (Non-CE)
2:15 PM – 3:15 PM
John G. Kuhn Keynote Address: I’m Not Limping. That’s Swagger! (Non-CE)Location: BallroomKeynote Speaker: – Kelsey Tainsh LLC
Kelsey Tainsh, Bachelor of Science in Recreation, Patient Advocate and Two time pediatric brain tumor and stroke survivor (she/her/hers) – Kelsey Tainsh LLC ### 1774212###Keynote Speaker###Professional Speaker###Kelsey Tainsh LLC###Keynote Speaker: – Kelsey Tainsh LLC
### she/her/hers3:30 PM – 4:45 PM
Optimizing Decision-Making for Treatment in Metastatic Renal Cell Carcinoma (mRCC): Balancing Evidence and Care Issues
3:30 PM – 4:45 PM
206 - Optimizing Decision-Making for Treatment of Metastatic Renal Cell Carcinoma (mRCC): Balancing Evidence and Care IssuesLocation: 160-163Speaker: – UConn School of Pharmacy
Co-Speaker: – University of Cincinnati James L. Winkle College of Pharmacy
Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP – UConn School of Pharmacy ### 1410920###Speaker###Clinical Professor###UConn School of Pharmacy###Speaker: – UConn School of Pharmacy
### @@@ Rowena N. Schwartz, PharmD, BCOP, FHOPA (she/her/hers) – University of Cincinnati James L. Winkle College of Pharmacy ### 894806###Co-Speaker###Professor of Pharmacy Practice###University of Cincinnati James L. Winkle College of Pharmacy###Co-Speaker: – University of Cincinnati James L. Winkle College of Pharmacy
### she/her/hers
3:30 PM – 4:45 PM
The Great Debate: Graft Versus Host Disease (GVHD) Prophylaxis Strategies (Encore)
3:30 PM – 4:45 PM
BC4 - The Great Debate: Graft Versus Host Disease (GVHD) Prophylaxis Strategies (Encore)Location: BallroomCo-Speaker: – Emory Healthcare - Winship Cancer Institute
Co-Speaker: – Mayo Clinic
Co-Speaker: – Moffitt Cancer Center
BCOP
Arpita Gandhi, PharmD, BCOP – Emory Healthcare - Winship Cancer Institute ### 1774202###Co-Speaker###Hematology/Oncology Clinical Pharmacy Specialist###Emory Healthcare - Winship Cancer Institute###Co-Speaker: – Emory Healthcare - Winship Cancer Institute
### @@@ Alexis K. Kuhn, PharmD, BCOP (she/her/hers) – Mayo Clinic ### 894768###Co-Speaker###Pediatric Oncology Pharmacist- Ambulatory Services###Mayo Clinic###Co-Speaker: – Mayo Clinic
### she/her/hers @@@ Rebecca Gonzalez, PharmD (she/her/hers) – Moffitt Cancer Center ### 900574###Co-Speaker###Clinical Pharmacist in Blood and Marrow Transplant/Cellular Immunotherapy###Moffitt Cancer Center###Co-Speaker: – Moffitt Cancer Center
### she/her/hers
5:00 PM – 7:30 PM
E-Poster Reception - Completed & Late Breaking Research + Trainee Top Ten
5:00 PM – 7:30 PM
E-Poster Reception - Completed & Late Breaking Research + Trainee Top TenLocation: Exhibit HallResearch
6:30 PM – 7:30 PM
Non-CE Symposia: LUNSUMIO (mosunetuzumab-axgb): A Novel, First-in-class, T-cell Engaging Bispecific Antibody in 3L+ Follicular Lymphoma
6:30 PM – 7:30 PM
Non-CE Symposia: LUNSUMIO (mosunetuzumab-axgb): A Novel, First-in-class, T-cell Engaging Bispecific Antibody in 3L+ Follicular LymphomaLocation: 158
Ramiro Garza III ### 1896106###*Speaker#########*Speaker:
### 6:30 PM – 7:30 PM
Non-CE Symposia: Treatment and management of myelofibrosis
6:30 PM – 7:30 PM
Non-CE Symposia: Treatment and management of myelofibrosis
Location: 159
6:30 PM – 8:00 PM
IRC Reception (Invite Only)
6:30 PM – 8:00 PM
IRC Reception (Invite Only)
Location: Hyatt (Second Floor)
